Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
June 29, 2017 Sen. Murray Releases New Committee Report That Shows How Devastating Trumpcare Would Be to Efforts to Combat the Opioid Crisis Sen. Ron Wyden Washington, DC
May 24, 2017 Letter to the Hon. Donald J. Trump, President - Delay Visit of Filipino Leader, Denounce Human Rights Abuses Sen. Jeffery Merkley Washington, DC
May 24, 2017 Letter to the Hon. Donald J. Trump, President - Delay Visit of Filipino Leader, Denounce Human Rights Abuses Sen. Ron Wyden Washington, DC
May 19, 2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Suzanne Bonamici Washington, DC
May 19, 2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Peter DeFazio Washington, DC
May 17, 2017 Letter to the Honorable Roy Blunt and Patty Murray, Chairman and Ranking Member of Senate Appropriations Subcommittee on Labor, HHS, and Education, and the Honorable Thad Cochran and Patrick Leahy, Chairman and Vice-Chairman of Senate Appropriations Committee - Increase Funding to Combat Opioid Epidemic Sen. Ron Wyden Unknown
May 17, 2017 Letter to the Honorable Roy Blunt and Patty Murray, Chairman and Ranking Member of Senate Appropriations Subcommittee on Labor, HHS, and Education, and the Honorable Thad Cochran and Patrick Leahy, Chairman and Vice-Chairman of Senate Appropriations Committee - Increase Funding to Combat Opioid Epidemic Sen. Jeffery Merkley Unknown
May 16, 2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Reductions to the Office of the National Drug Control Policy Rep. Peter DeFazio Unknown
May 16, 2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Reductions to the Office of the National Drug Control Policy Rep. Suzanne Bonamici Unknown
May 8, 2017 Letter to AmerisourceBergen Corporation, CardinalHealth, McKesson Corporation and the Drug Enforcement Administration - Alleged Pill Dumping in West Virginia Rep. Greg Walden Washington, DC
May 5, 2017 Letter to the Hon. Tom Price, Secretary of Health and Human Services - Delay Federal Opioid Workshop Until Industry Conflicts are Examined Sen. Ron Wyden Washington, DC
April 19, 2017 HHS to Issue First Round of Opioid Grants from 21st Century Cures Act Rep. Greg Walden Washington, DC
April 11, 2017 Letter to the Hon. Donald Trump, President- Help Fight Opiod Epidemic Sen. Ron Wyden Washington, DC
April 4, 2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices Rep. Peter DeFazio Washington, DC
April 4, 2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices Rep. Earl Blumenauer Washington, DC
April 4, 2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices Rep. Suzanne Bonamici Washington, DC
March 29, 2017 As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices Sen. Jeffery Merkley Washington, DC
March 29, 2017 E&C Leaders Comment on President Trump's Executive Action to Address Opioid Epidemic Rep. Greg Walden Washington, DC
March 21, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Fentanyl: The Next Wave of the Opioid Crisis Rep. Greg Walden Washington, DC
March 15, 2017 Wyden Slams Republican Vote to Create "Bedlam" for Drug Testing of Unemployed Americans Sen. Ron Wyden Washington, DC
Feb. 28, 2017 #SubOversight Examines International Anti-Doping System With All-Star Panel Rep. Greg Walden Washington, DC
Feb. 23, 2017 Letter to Mr. Kemp Chester, Acting Director of the the Office of National Dug Control Policy - Provide Assistance in Questioning all Federal Agencies on Plans to Address Fentanyl Rep. Greg Walden Washington, DC
Feb. 23, 2017 Letter to Secretary of State Rex Tillerson and Department of Homeland Security Secretary John Kelly - Reaffirm the Strategic Importance of the U.S.-Mexico Partnership Sen. Jeffery Merkley Washington, DC
Feb. 21, 2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike Rep. Kurt Schrader Washington, DC
Feb. 21, 2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike Rep. Earl Blumenauer Washington, DC
Feb. 21, 2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike Rep. Peter DeFazio Washington, DC
Feb. 21, 2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike Rep. Suzanne Bonamici Washington, DC
Feb. 20, 2017 Senators View Security, Immigration Processing Operations at U.S.-Mexico Border Sen. Jeffery Merkley Washington, DC
Feb. 17, 2017 Letter to the Hon. Jean-Claude Junker, President of the European Commission - European Union Support to Combat the Fentanyl Crisis Sen. Ron Wyden Washington, DC
Dec. 8, 2016 Wyden Asks Congress to Pass Historic Bipartisan, Bicameral Child Welfare Reform Bill Sen. Ron Wyden Washington, DC
Dec. 1, 2016 Letter to the Hon. Paul Ryan, Speaker of the House, the Hon. Mitch McConnell, Senate Majority Leader; the Hon. Nancy Pelosi, House Minority Leader and the Hon. Harry Reid, Senate Minority Leader - Call for Passage of Foster Care Reforms Sen. Ron Wyden Washington, DC
Nov. 15, 2016 Opioid Addiction Sen. Ron Wyden Washington, DC
Oct. 26, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States - Leahy Presses Administration to Take On Opioid Distributors Sen. Ron Wyden Washington, DC
Oct. 26, 2016 The Lund Report - Schrader Wants to Speed Up Approval Time for Generic Drugs Rep. Kurt Schrader Washington, DC
Oct. 14, 2016 Letter to Mr. Werner Sipp, President, International Narcotics Control Board - Take Action to Regulate Fentanyl Sen. Ron Wyden Washington, DC
Oct. 13, 2016 Letter to Mr. Werner Sipp, President of the Intl. Narcotics Control Board - Call on UN to Take Action to Regulate Precursor Chemicals of Fentanyl Sen. Ron Wyden Washington, DC
Oct. 12, 2016 Wyden Report: Opioid Funds Lacking, Nationwide Epidemic Will Continue to Rage Sen. Ron Wyden Washington, DC
Oct. 10, 2016 Wyden Report Shows Only 1 in 10 Oregonians with Opioid Addiction Receiving Needed Treatment Sen. Ron Wyden Portland, OR
Oct. 7, 2016 Wyden Statement on Mylan Settlement Sen. Ron Wyden Unknown
Sept. 30, 2016 Wyden, Booker, Gillibrand Express Concern about DEA Process to Schedule Kratom Sen. Ron Wyden Washington, DC
Sept. 28, 2016 Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades Sen. Ron Wyden Washington, DC
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep. Earl Blumenauer Washington, DC
Sept. 23, 2016 Salem Statesman Journal - Schrader Bill to Speed Development of Generic Drugs Gains Momentum Rep. Kurt Schrader Washington, DC
Sept. 5, 2016 Washington Post - A Better Way to Help Vulnerable Children and Families Sen. Ron Wyden Unknown
Aug. 15, 2016 "Combating mental illness and drug addiction in our communities" Rep. Greg Walden Unknown
Aug. 11, 2016 Merkley Statement on DEA's Decision Not to Reschedule Marijuana Sen. Jeffery Merkley Portland, OR
Aug. 11, 2016 Wyden: Federal Law "Behind the Times' with DEA Decision Not to Reschedule Marijuana Sen. Ron Wyden Washington, DC
Aug. 10, 2016 Congressman Blumenauer Statement on Expected DEA Marijuana Announcement Rep. Earl Blumenauer Washington, DC
Aug. 2, 2016 Letter to The Honorable Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services - Urging CMS to Expand Substance Abuse Treatment Coverage Sen. Jeffery Merkley Washington, DC
July 27, 2016 Wyden Alarmed By Dramatic Rise of Illicit Fentanyl Sen. Ron Wyden Washington, DC
July 14, 2016 The Family First Prevention Services Bill Sen. Ron Wyden Washington, DC
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic Sen. Ron Wyden Washington, DC
July 14, 2016 Murray, Wyden, Leahy, Shaheen Continue Work on Opioid Epidemic, Introduce Legislation to Fund Needed Treatment & Recovery Efforts Sen. Ron Wyden Washington, DC
July 14, 2016 S. Comprehensive Addiction and Recovery Act Rep. Suzanne Bonamici Washington, DC
July 13, 2016 Wyden Statement on Passage of CARA Opioid Legislation Sen. Ron Wyden Unknown
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill Sen. Ron Wyden Washington, DC
July 13, 2016 Federal Aviation Administration Reauthorization Act of 2016 Sen. Ron Wyden Washington, DC
July 8, 2016 Greg Walden Applauds U.S. House Approval of Plan to Combat Nation's Opioid Epidemic Rep. Greg Walden Washington, DC
July 6, 2016 Wyden Disappointed in Multi-Million Dollar Windfall for Drug Makers Instead of Care for Pregnant Women in Opioid Conference Report Sen. Ron Wyden Washington, DC
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic Sen. Ron Wyden Washington, DC
July 1, 2016 Letter to Dr. Victoj J. Dzau, M.D., President, National Academy of Medicine - Concerns Regarding National Academy Committee Ties to Opioid Manufacturers Sen. Ron Wyden Washington, DC
June 23, 2016 Letter to The Honorable Loretta E. Lynch, Attorney General, U.S. Department of Justice, and The Honorable Chuck Rosenberg, Acting Administrator, Drug Enforcement Administration - Requesting Update on Federal Marijuana Rescheduling Decision Sen. Jeffery Merkley Washington, DC
June 23, 2016 Letter to The Honorable Loretta E. Lynch, Attorney General, U.S. Department of Justice, and The Honorable Chuck Rosenberg, Acting Administrator, Drug Enforcement Administration - Requesting Update on Federal Marijuana Rescheduling Decision Sen. Ron Wyden Washington, DC
June 16, 2016 Finance Senators Introduce Family First Prevention Services Act Sen. Ron Wyden Washington, DC
June 15, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request for Information on Surge of Illegally-Produced Fentanyl Sen. Ron Wyden Washington, DC
June 10, 2016 Bipartisan House, Senate Leaders Announce Proposed Child Welfare Legislation Sen. Ron Wyden Washington, DC
June 1, 2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment Sen. Jeffery Merkley Washington, DC
May 20, 2016 Letter to Gil Kerlikowske, Commissioner and Border Patrol - Concerns on the Dangers of Powerful Opioid Fentanyl Sen. Ron Wyden Washington, DC
May 19, 2016 Merkley, Mikulski and Manchin Push For More Action on Opioid Abuse in Senate Spending Bill Sen. Jeffery Merkley Washington, DC
May 13, 2016 Providing for Consideration of S. Comprehensive Addiction and Recovery Act of 2016 Rep. Suzanne Bonamici Washington, DC
May 12, 2016 House Passes Blumenauer Amendment to Increase Access to Safe Medication Disposal Rep. Earl Blumenauer Washington, DC
May 12, 2016 Statement from Rep. Peter DeFazio on Comprehensive Opioid Abuse Reduction Act Rep. Peter DeFazio Unknown
May 12, 2016 Comprehensive Opioid Abuse Reduction Act of 2016 Rep. Earl Blumenauer Washington, DC
May 11, 2016 Blumenauer Announces Measures to Increase Access to Safe Medication Disposal Rep. Earl Blumenauer Washington, DC
May 11, 2016 Establishing Pain Management Best Practices Inter-Agency Task Force Rep. Greg Walden Washington, DC
May 11, 2016 Recognizing the Need for Safe Disposal of Prescription Medicines Rep. Earl Blumenauer Washington, DC
May 11, 2016 War on Drugs Rep. Earl Blumenauer Washington, DC
May 4, 2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic Rep. Suzanne Bonamici Washington, DC
May 4, 2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic Rep. Earl Blumenauer Washington, DC
April 27, 2016 Wyden Proposes Cap on Prescription Drug Costs Sen. Ron Wyden Washington, DC
April 27, 2016 UNGASS Reflections Rep. Earl Blumenauer Washington, DC
April 21, 2016 Blumenauer on UN Special Session on Drug Policy: We Need a More Just and Compassionate Approach Rep. Earl Blumenauer Washington, DC
April 20, 2016 War on Drugs Rep. Earl Blumenauer Washington, DC
April 19, 2016 Merkley Denounces Lack of Action on E-cigarette Rules Sen. Jeffery Merkley Washington, DC
April 15, 2016 Letter to the Honorable Barack Obama, President of the United States - Call to Remove Barriers to Research on Medical Marijuana Sen. Ron Wyden Washington, DC
April 15, 2016 Letter to the Honorable Barack Obama, President of the United States - Call to Remove Barriers to Research on Medical Marijuana Sen. Jeffery Merkley Washington, DC
April 15, 2016 Letter to the Honorable Barack Obama, President of the United States - Call to Remove Barriers to Research on Medical Marijuana Rep. Earl Blumenauer Washington, DC
April 14, 2016 Marijuana Debate Rep. Earl Blumenauer Washington, DC
April 1, 2016 Greg Walden Backs Effort to Maintain Life-Saving Emergency Medical Services for Patients Rep. Greg Walden Medford, OR
March 18, 2016 Schrader, Bilirakis Introduce Lower Drug Costs Through Competition Act Rep. Kurt Schrader Washington, DC
March 10, 2016 Comprehensive Addiction and Recovery Bill Sen. Ron Wyden Washington, DC
March 2, 2016 Comprehensive Addiction and Recovery Act of 2015 Sen. Ron Wyden Washington, DC
Feb. 29, 2016 Merkley Statement on Senate Action to Take on Opioids Crisis Sen. Jeffery Merkley Washington, DC
Feb. 29, 2016 Opioid Addiction Sen. Ron Wyden Washington, DC
Feb. 24, 2016 Opioid Abuse/Medical Marijuana Rep. Earl Blumenauer Washington, DC
Feb. 23, 2016 Hearing of the Senate Committee on Finance - Opening Statement of Sen. Ron Wyden - Hearing on Opioids Sen. Ron Wyden Washington, DC
Dec. 21, 2015 Letter to Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services, Michael Botticelli, Director of the Office of National Drug Control Policy, and Chuck Rosenberg, Acting Adminstrator of the Drug Enforcement Administration - Medical Marijuana Research Sen. Jeffery Merkley Washington, D.C.
Dec. 21, 2015 Letter to Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services, Michael Botticelli, Director of the Office of National Drug Control Policy, and Chuck Rosenberg, Acting Adminstrator of the Drug Enforcement Administration - Medical Marijuana Research Sen. Ron Wyden Washington, D.C.
Oct. 28, 2015 Regulating Tobacco Sen. Jeffery Merkley Washington, DC
June 5, 2015 House Passes Massie's Bipartisan Hemp Amendment Rep. Suzanne Bonamici Washington, DC
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top